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Abstract: Chemical investigation of the ethyl acetate extract from the marine-derived Streptomyces sp.
isolate B1848 resulted in three new isoquinolinequinone derivatives, the mansouramycins E–G (1a–3a),
in addition to the previously reported mansouramycins A (5) and D (6). Their structures were elucidated
by computer-assisted interpretation of 1D and 2D NMR spectra, high-resolution mass spectrometry, and
by comparison with related compounds. Cytotoxicity profiling of the mansouramycins in a panel of up
to 36 tumor cell lines indicated a significant cytotoxicity and good tumor selectivity for mansouramycin
F (2a), while the activity profile of E (1a) was less attractive.
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The first natural isoquinolinequinone isolated from bacteria were reported by Fukum et al.
in 1977 [1] and then by Kubo et al. in 1988 [2]. A few others were isolated from porifera,
including cribrostatins (produced by the blue marine sponge Cribrochalina sp.) [3], renierones (from Reniera, Petrosia, and Haliclona spp.) [4,5], and caulibugulones (found in the
marine bryozoon Caulibugula inermis) [6]. These isoquinolinequinones showed a potent
antimicrobial activity against Gram positive bacteria and yeast (Candida albicans) and a
pronounced cytotoxicity against L1210 and other cell lines with IC50 values as low as
30 ngmL−1 [7,8]. In 1998, we isolated mansouramycin A (5) as a trace component from
the marine derived Streptomyces sp. B3497 [9]. Mansouramycin A (5) and the synthetic
analogue 3-methyl-7-(methylamino)-5,8-isoquinolinedione (4a) were re-isolated from the
marine-derived Streptomyces sp. isolate Mei37, together with three new mansouramycins
B–D (1a–3a) [10]. These compounds showed a pronounced selectivity for non-small cell
lung cancer, breast cancer, melanoma, and prostate cancer cells. Recently, mansouramycin
A (5) was also obtained from the marine-derived Streptomyces albus J1074 and found to
be a potent inhibitor of the methicillin-resistant Staphylococcus aureus ATCC 43300 with
an MIC of 8 µgmL−1 . S. albus J1074 produced additionally the novel isoindoloquinone
albumycin [11].
While the marine-derived Streptomyces sp. isolate B1848 was previously noted as a
producer of 6-hydroxy-isatine and several other known compounds [12–14], further fermentations led now to the isolation and characterization of three unusual mansouramycins
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linequinones gave brown-red zones on TLC, with UV absorptions in solution similar as of
gave brown-red zones on TLC, with UV absorptions in solution similar as of periperi-hydroxyquinones. Their reversible color change with sodium dithionite from orange to
hydroxyquinones. Their reversible color change with sodium dithionite from orange to
nearly colorless confirmed quinones; peri-hydroxyquinones were excluded, however, by the
nearly colorless confirmed quinones; peri-hydroxyquinones were excluded, however, by
missing bathochromic shift with sodium hydroxide. Unlike the orange-red phenoxazinone
the missing bathochromic shift with sodium hydroxide. Unlike the orange-red
chromophore of actinomycins and related pigments, which are becoming red with conphenoxazinone chromophore of actinomycins and related pigments, which are becoming
centrated sulfuric acid, the isoquinolinequinones turned yellow. Further physicochemical
red with concentrated sulfuric acid, the isoquinolinequinones turned yellow. Further
properties of compounds 1a−3a are summarized in Table 1.
physicochemical properties of compounds 1a−3a are summarized in Table 1.
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Table 1. Physico-chemical properties of mansouramycins E–G (1a–3a).
Analytical Methods

Mansouramycin E (1a)

Appearance
Rf

a

Mansouramycin F (2a)

Mansouramycin G (3a)

Red powder

Dark red solid

Red solid

0.76 (CH2 Cl2 /7% MeOH)

0.50 (CH2 Cl2 /7% MeOH)

0.23 (CH2 Cl2 /7% MeOH).

Anisaldehyde/H2 SO4 reagent

yellow

yellow

yellow

Staining with NaOH

no color change

no color change

no color change

Molecular Formula

C16 H11 N3 O2

C12 H9 N3 O2

C15 H11 N3 O4

UV/vis λmax (log ε)

(MeOH): 244 (4.17), 264 (4.20), 287 sh
(4.17), 314 sh (3.71), 377 (3.94), 448 sh
(3.28), 509 sh (3.17); (MeOH + 1N
NaOH): 243 (4.16), 263 (4.21), 287 sh
(4.17), 313 sh (3.77) 378 (3.94), 449 sh
(3.47), 508 sh (3.17); (MeOH + 1N HCl)
245 sh (4.04), 267 (4.14), 284 sh (4.02) 314
sh (3.31) 387 (3.91), 510 (3.17) nm

(MeOH): 234 (3.66), 288 (3.26), 373 (3.22),
481 sh (2.38); (MeOH+ 1N HCl): 237
(3.53), 313 (3.38), 378 (3.12), 485 sh (2.38)
nm; (MeOH+1N NaOH): 233 (3.64), 289
(3.28), 375 (3.19), 485 sh (2.38) nm

(MeOH): 244 (4.13), 299 sh (3.65), 382
(3.42), 435 nm (3.47); (MeOH + 1N
HCl): 243 (4.05), 303 (3.65), 377 (3.46),
436 (3.47); (MeOH + 1N NaOH): 245
(4.07), 302 sh (3.57), 384 (3.35),
437 (3.35) nm

IR (KBr) νmax (KBr)

3434, 2925, 2855, 1672, 1625, 1598, 1510,
1491, 1412, 1384, 1354, 1311, 1268,
1208, 1050 cm−1

3419, 2926, 2856, 1669, 1595, 1543, 1515,
1489, 1420, 1384, 1336, 1264, 1097,
1028, 764, cm−1

3426, 2925, 2855, 1616, 1559, 1544,
1458, 1412, 1384, 1325, 1261, 1028 cm−1

245.0 ([M+NH4 ]+ , 5),
228.0 ([M+H]+ , 100)

CI-MS: m/z (%)
(+)-ESI-MS: m/z (%)

278 ([M+H]+ )

EI-MS: m/z (%)

277 [M]+ (84), 256 (8), 249 (12), 236 (15),
220 (11), 195 (8), 192 (13), 179 (9), 166
(24), 138 (13), 102 (8), 97 (15), 82 (28), 73
(36), 69 (42), 57 (72), 43 (76), 44 (100)

320.2 ([M+Na]+ , 31),
617.0 ([2M+Na]+ , 100)
227 ([M]+. , 100), 199 ([M-CO]+. , 8), 186
(16), 145 (9), 116 (8), 59 (12), 43 (8)
228.07663 [M+H]+

(+)-ESI-HRMS: m/z
Calcd.

277.0846 for C16 H11 N3 O2

EI HRMS: m/z

228.07667 for C12 H10 N3 O2 [M+H]

298.08203 [M+H]+
+

298.08223 for C15 H12 N3 O4 [M+H]+

277.0848
a

Silica gel G/UV254 ; 1b, 2b, 3b (CH2 Cl2 /7% MeOH); sh = shoulder.

2.1. Structure Elucidation
Compound 1a was obtained as red powder of moderate polarity. The molecular formula was determined as C16 H11 N3 O2 by EI-HRMS, indicating 13 double bond equivalents
(DBE). The color change to yellow with concentrated sulfuric acid and the characteristic UV
curve with a flat absorption at λmax 509 nm as for 5, 6 pointed to an isoquinolinequinone
moiety as well [10] (Table 1). The 13 C NMR spectrum (Table 2) showed six aromatic/olefinic
methines and one methyl signal. Furthermore, signals of nine non-protonated carbon atoms
were observed, of which two at δ 182.8 and 181.4 pointed to carbonyl groups of a quinone.
In the proton NMR spectrum (Table 2), the CH singlets at δ 9.01 (H-1) and 5.71 (H-6), in
addition to a broadened NH signal at δ 7.83 and a methyl doublet at δ 2.85 of the CH3 NH
fragment were typical for mansouramycins.
The proton H-6 showed HMBC correlations (Figure 2) with C-4 (4 J), 4a, 5, 7, and C-8;
correlations of the N-methyl signal with C-7, and of H-1 with C-3, 4a and 8 resulted in a
3,4-disubstitued 7-methylamino-isoquinolinequinone skeleton as in 4a–6; unfortunately,
NH HMBC correlations were not visible for 1a.
A 1,2-disubstituted benzene ring was deduced from the typical signal pattern of
four o,m-coupled protons at δ 8.23 (d), 7.79 (d), 7.61 (td), and 7.31 (td) ppm and from the
expected HMBC correlations (Figure 2). A further broadened NH signal was seen at δ 11.98,
which formed with the remaining atoms an aniline residue. With respect to the two open
valencies in both fragments, the isoquinoline and the aniline unit can be merged only in
two ways under formation of structures 1a or 1b. The more in-depth analysis of the NMR
data by means of the structure elucidation program COCON [15] confirmed isomers 1a
and 1b as allowed structures, but delivered >7600 additional alternatives! Most of them
were highly strained (cyclobutenes, non-linear allenes, or bridged aromatic systems) and
therefore excluded.
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(150 MHz) and 1 H NMR spectroscopic data of compounds 1a–3a in DMSO-d6 (δ in ppm, J in [Hz]).

Mansouramycin E (1a)
Position

δH (Mult, J in [Hz]) (a)

δC , Type

Mansouramycin F (2a)
δC , Type

δH (Mult, J in [Hz]) (b)

Mansouramycin G (3a)
δC , type

δH (Mult, J in [Hz]) (a)

1
139.0, CH
9.01 (s)
140.7, CH
8.90 (s)
150.4, CH
9.31 (s)
3 Drugs 2021,
149.9,19,
C x FOR PEER REVIEW
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4
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4a
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6
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99.0, CH
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7
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pyrroloisoquinoline-5,8-quinones. The results (Table S2) pointed again clearly to structure
2a for mansouramycin F. This conclusion was further confirmed by comparison with
similarly fused pyrrolo-pyridine skeletons [18,19].
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With COCON using atom types, 19 isomers were found. Four of them were quinones (2a,
2b, S2c, S2d). The other structures were azepin-2-ones or highly strained bridged systems.
Isomers of type S2m were excluded by COCON as well, and also o-quinones were not
predicted for mansouramycin F.
H-30 in 2b should show a 3 J correlation with C-4a, which is missing in the experimental
spectrum and therefore better fitting on 2a. In S2c/S2d, the quinonoid proton H-7 (δ ~5.6)
should show a 3 J correlation with C-8a at δ ~147. However, this was also not observed,
so that only structure 2a was left. For further confirmation, we compared the experimental with calculated shifts of all possible pyrrolo-quinoline- and pyrroloisoquinoline-5,8quinones. The results (Table S2) pointed again clearly to structure 2a for mansouramycin F.
This conclusion was further confirmed by comparison with similarly fused pyrrolo-pyridine
skeletons [18,19].
Compound 3a was obtained as a red solid as well, which displayed isoquinolinequinone-like UV/vis and other physicochemical properties. The molecular formula of
3a was established as C15 H11 N3 O4 by ESI-HRMS and 1 H and 13 C NMR analysis, entailing 12 DBE. The 1 H and 13 C NMR spectra confirmed a further isoquinoline-quinone,
which showed, however, remarkable differences compared with 1a and 2a. Instead of
one N-methyl residue (7-NHCH3 ) and one quinonoid proton (6-H), as in the other mansouramycins, the 1 H NMR spectrum showed each two of these signals. In addition, the
13 C NMR spectrum displayed four carbonyl groups (δ 178.2, 179.8, 177.6, and 180.9)
C
instead of two carbonyls as in 1a and 2a (Table 2). Interpretation of the HMBC spectrum
of 3a (Figure 2) revealed an isoquinoline-quinone and an N-methylaminobenzoquinone
substructure, which can be connected in two different ways only, resulting in 3a or 3b,
respectively (Figures 1 and 2). The alternative 3b was excluded, however, based on the
significant 3 J HMBC correlations of H-6 (δH 5.75) and NH-9 (δH 7.84) with CO-8 (δC 179.8)
and not with CO-5 (δC 178.2); the position of the second N-methyl group at C-30 was
determined in a similar way. All the remaining HMBC and COSY correlations (Figure 2)
were in full agreements with structure 3a, a novel azaphenanthrene diquinone, which we
named mansouramycin G (see also Supplementary Materials).
2.2. Biological Activities
Isolated compounds were evaluated in cytotoxicity assays against the same 36 cancer
cell lines as published before [10]. Consistent with results previously reported herein
for other members of the group, cytotoxicity profiling of the new mansouramycin 2a revealed good anti-tumor activity in vitro with a mean IC50 value of 7.92 µM (1.797 µgmL−1 ).
Furthermore, 2a showed good tumor selectivity across the panel of 36 cell lines. Mansouramycin E (1a) was less active and selective [mean IC50 = 23.10 µM (6.398 µgmL−1 )].
Previously reported mansouramycins C (4b) and A (5) exhibited mean IC50 values of
0.089 µM (0.022 µgmL−1 ) and 13.44 µM (2.902 µgmL−1 ), respectively (Table 3). Mansouramycin G (3a) was not tested, due to a lack of material. In the agar diffusion test, crude
extracts of S. isolate B1848 exhibited high bioactivity against Mucor miehei (Tü 284) and
Candida albicans, and moderate activity against Escherichia coli and the alga Chlorella vulgaris.
The samples of 1–6 were nearly consumed in the cytotoxicity assays and therefore not
tested for their antimicrobial activity.
Table 3. In vitro cytotoxic activities of mansouramycins A (5), C (4b), E (1a), and F (2a).
Potency

Tumor Selectivity

Compound

Mean IC50 µM
(µgmL−1 )

Mean IC70 µM
(µgmL−1 )

Selectivity */Total

% Selectivity

Rating **

Internal Code

Mansouramycin A (5)
Mansouramycin C (4b)
Mansouramycin E (1a)
Mansouramycin F (2a)

13.44 (2.902)
0.089 (0.022)
23.10 (6.398)
7.92 (1.797)

26.26 (5.671)
0.167 (0.041)
33.95 (9.405)
15.19 ((3.449)

4/36
10/36
0/18
7/36

11%
28%
0%
19%

++
+++
++

MNSG078
MNSG091
MNSG089
MNSG090

* individual IC70 < 1/3 mean IC70 ; e.g., if mean IC70 = 2.1 µM the threshold for above average sensitivity was IC < 0.7 µM, ** - (% selective
= < 4%); + (4% > %selective >= 10%); ++ (10% > %selective >= 20%); +++ (% selective > 20%).
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3. Materials and Methods
3.1. General Procedures
NMR spectra were measured on Varian Unity 300 and Varian Inova 600 spectrometers.
The spectra were referenced to the signals of partially deuterated solvents (δChl 7.270, 77.000;
δDMSO 2.500, 39.510). Electron spray ionization mass spectrometry (ESI HRMS): Finnigan
LCQ ion trap mass spectrometer coupled with a Flux Instruments (Basel, Switzerland)
quaternary pump Rheos 4000 and a HP 1100 HPLC (nucleosil column EC 125/2, 100-5,
C 18) with autosampler (Jasco 851-AS, Jasco Inc., Easton, MD, USA) and a Diode Array
Detector (Finnigan Surveyor LC System). High resolution mass spectra (HRMS) were
recorded by ESI MS on an Apex IV 7 Tesla Fourier-Transform Ion Cyclotron Resonance
Mass Spectrometer (Bruker Daltonics, Billerica, MA, USA). EI mass spectra (70 eV) were
recorded on a Finnigan MAT 95 spectrometer (Thermo Electron Corp., Bremen, Germany)
with perfluorokerosene as reference substance for EI HRMS. IR spectra were recorded on
a Perkin-Elmer 1600 Series FT-IR spectrometer from KBr pellets. UV/vis spectra were
recorded on a Perkin-Elmer Lambda 15 UV/vis spectrometer. Flash chromatography
was carried out on silica gel (230–400 mesh). Rf -values were measured on Polygram SIL
G/UV254 (Macherey-Nagel & Co., Düren, Germany). Size exclusion chromatography
was carried out on Sephadex LH-20 (Lipophilic Sephadex; Amersham Biosciences, Ltd.,
purchased from Sigma-Aldrich Chemie, Steinheim, Germany).
3.2. Isolation and Taxonomy of the Producing Strain
The marine Streptomyces sp. strain B1848 was isolated and deposited in the Actinomycetes culture collection of the Alfred-Wegner Institute for Polar- und Marine Research,
Am Handelshafen, Bremen, Germany. The taxonomy of the strain has been described
previously [12].
3.3. Fermentation and Working Up
The S. sp. isolate B1848 was previously cultivated on M2 + medium with 50% seawater
in a 25 L jar fermenter (72 h at 28 ◦ C) [12,13]. Optimization of the culture conditions has
been performed now using six different media [14] at two pH values (6.5, 7.8), temperatures
(28, 35 ◦ C), and shaking rates (110, 95 rpm) for four days. TLC analysis and antimicrobial
screenings indicated that medium C (meat extract medium: 10 g glucose, 2 g peptone,
1 yeast, 1 g meat extract, pH 7.8) gave the best yield of mansouramycins.
A 50-L jar fermenter with C-medium was inoculated with strain B1848 and stirred
for 4 days at 28 ◦ C with 120 rpm. The resulting pale yellow culture broth was mixed with
diatomaceous earth (Celite, ca. 1.8 kg), and filtered-off under pressure. The mycelial cake
was extracted with ethyl acetate (3×), and then with acetone (2×). The acetone extract was
concentrated under reduced pressure, and the aqueous residue was extracted once more
with ethyl acetate. The combined organic phases were concentrated in vacuo, yielding
4.8 g of reddish-orange residue. None of the compounds of interest were detected in the
aqueous phases, and therefore they were discarded.
3.4. Isolation and Purification
The mycelial cake extract (4.8 g) was applied to flash silica gel column chromatography (3 × 60 cm) using a CH2 Cl2 -CH3 OH gradient. After monitoring by TLC (CHCl3 /5;
10% MeOH), four fractions were obtained. Purification of fractions II-IV, using PTLC and
Sephadex LH 20, led to isolation of five dark red compounds: mansouramycin A (5; 3.0 mg),
D (6, 8.0 mg), E (1a; 4.1 mg), F (2a; 6.0 mg), and mansouramycin G (3a; 4.2 mg); for the
physico-chemical properties and NMR spectral data of mansouramycins E–G (1–3), see
Tables 1 and 2, respectively.
Mansouramycin C (3-Carbomethoxy-7-methylaminoisoquinoline-5,8-dione; 4b): During this investigation, we realized two errors in the previously reported 13 C NMR data
of mansouramycin D [10]: (CDCl3 , 150 MHz): δ 180.6 (Cq -8), 179.8 (Cq -5), 164.3 (Cq -9),
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153.3 (Cq -3), 148.8 (Cq -7), 148.0 (CH-1), 140.5 (Cq -4a), 126.0 (Cq -8a), 120.7 (CH-4), 101.5 (CH-6),
53.4 (9-OCH3 ), 29.3 (NCH3 ).
Mansouramycin F (7-Methylamino-3H-pyrrolo [2,3-c]-isoquinoline-6,9-dione, 2a):
1 H NMR (CDCl , 300 MHz): δ 10.25 (s br, 1H, NH-10 ), 9.12 (s, 1H, 1-H), 7.79 (t, 3 J = 2.6 Hz,
3
1H, 20 -H), 6.81 (t, 3 J = 2.9 Hz, 1H, 30 -H), 6.25 (s br, 1H, 9-NH), 5.69 (s, 1H, 6-H), 2.98 (d, J =
5.1 Hz, 3H, CH3 -10).
Data of mansouramycins E–G (1a–3a) are listed in Tables 1–3, and spectra are depicted
in the Supplementary Information. The working up and isolation of mansouramycins E–G
(1a–3a) was carried out in August 2004. Spectral measurements, structural interpretation,
and biological activity testing of 1a–3a were achieved in the beginning of 2005.
3.5. Cytotoxicity Assays
A modified propidium iodide assay was used to examine the antiproliferative activity
of the compounds against human tumor cell lines. Cell lines tested were derived from
patient tumors engrafted as a subcutaneously growing tumor in NMRI nu/nu mice or
obtained from American Type Culture Collection, Rockville, MD, USA, National Cancer
Institute, Bethesda, MD, USA, or Deutsche Sammlung von Mikroorganismen und Zellkulturen, Braunschweig, Germany, and details of the test procedure have been described
previously [20–22]. For the results, see Table 3.
3.6. DFT-Calculations
The calculation of NMR shifts was performed in a sequence of six calculation steps
implemented in SPARTAN’20 [16]: (1) for all molecules of interest, the least energy conformers were determined using the “systematic approach” of the Merck Molecular Force
Field program (MMFF). Up to 500 MMFF conformers within 40 kJ/mol above the global
minimum were kept; in step (2), geometries were further optimized with a Hartry-Fock
calculation (HF/3-21G); up to 200 conformers with <40 kJ/mol above the global minimum
the energies were kept and (3) optimized (energies) with the DFT functional ωB97X-D
and the 6-31G* basis set; (4) for up to 100 conformers within a window of 15 kJ/mol, the
geometries were calculated now with the same functional and basis set; up to 50 conformers with <10 kJ/mol were kept for step (5); for the remaining conformers, energies
and Boltzmann factors (300 K) were calculated with ωB97X-V/6-311+G(2df,2p) [6-311G*];
(6) for up to 30 resulting conformers with <10 kJ/mol the NMR data were calculated with
ωB97X-D/6-31G* using the geometries from step (4). The conformer shifts were averaged
with the Boltzmann factors from step five.
4. Conclusions
Isoquinoline-quinones from marine invertebrates and associated streptomycetes attracted scientific attention due to their strong anticancer activities [1–6]. From marinederived Streptomyces spp., we isolated recently five isoquinoline-quinone derivatives, the
mansouramycins A-D and 3-methyl-7-(methylamino)-5,8-isoquinolinedione (4a), which
showed significant cytotoxicity in a panel of up to 36 tumor cell lines, with pronounced
selectivity for non-small cell lung cancer, breast cancer, melanoma, and prostate cancer cells [10]. After a culture optimization, we succeeded now to isolate three further
mansouramycins E–G (1a–3a) from the same marine Streptomyces sp. strain B1848, used
optimized culture conditions. Their structures were elucidated by computer-assisted interpretation of 1D and 2D NMR spectra, high resolution mass spectrometry, by comparison
with ab initio-calculated NMR data and by comparison with related compounds. Cytotoxicity profiling of the mansouramycins in a panel of up to 36 tumor cell lines indicated
only a moderate cytotoxicity and tumor selectivity for the new quinones E (1a) and F
(2a). The novel azaphenanthrene-diquinone mansouramycin G (3a) was not tested due to
insufficient material.
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